RecallDepth
Class III Terminated

Colchicine Tablets, USP 0.6 mg, Rx Only, a) 30 tablets per bottle, NDC 16714-0039-01, b) 100 tablets per bottle, NDC 16714-0039-02, Manufactured for: NorthStar Rx LLC., Memphis, TN 38141, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, c) 100 tablets per bottle, NDC 70710-1351-01, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.

Company
Zydus Pharmaceuticals (Usa) Inc
Recall Initiated
February 24, 2023
Posted
March 22, 2023
Recall Number
D-0467-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,936/30 count bottles and 33,096/100 count bottles
Firm Location
Pennington, NJ, United States

Reason for Recall

Failed Impurities/Degradation Specifications: An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine.

Distribution

AZ, OH, MS.

Lot / Code Info

Lot #s: a) E203821, Exp. 05/2024; b) E203822, Exp. 05/2024, E206186, Exp. 10/2024; c) E203820, Exp. 05/2024.

More recalls by Zydus Pharmaceuticals (Usa) Inc

View all recalls by this company →

Other recent Class III Drug recalls